Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening

作者: Wei Guo , Sheng Yao , Pu Sun , Tian-biao Yang , Chun-ping Tang

DOI: 10.1038/S41401-019-0246-4

关键词: BiochemistryDocking (molecular)Indoleamine 2,3-dioxygenaseHigh-throughput screeningChemistryEnzymeNon-competitive inhibitionRecombinant DNAUncompetitive inhibitorNatural product

摘要: … b The effects of 79 natural products on the activity of IDO1 using a method based on Ehrlich’… Compared with the existing IDO1 inhibitors, the inhibitors identified in this study exhibited …

参考文章(42)
Jian-Sung Wu, Shu-Yu Lin, Fang-Yu Liao, Wen-Chi Hsiao, Lung-Chun Lee, Yi-Hui Peng, Chia-Ling Hsieh, Mine-Hsine Wu, Jen-Shin Song, Andrew Yueh, Chun-Hwa Chen, Shiu-Hwa Yeh, Chia-Yeh Liu, Shu-Yi Lin, Teng-Kuang Yeh, John T.-A. Hsu, Chuan Shih, Shau-Hua Ueng, Ming-Shiu Hung, Su-Ying Wu, Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening Journal of Medicinal Chemistry. ,vol. 58, pp. 7807- 7819 ,(2015) , 10.1021/ACS.JMEDCHEM.5B00921
Nicholas C. D'Amato, Thomas J. Rogers, Michael A. Gordon, Lisa I. Greene, Dawn R. Cochrane, Nicole S. Spoelstra, Travis G. Nemkov, Angelo D'Alessandro, Kirk C. Hansen, Jennifer K. Richer, A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Research. ,vol. 75, pp. 4651- 4664 ,(2015) , 10.1158/0008-5472.CAN-15-2011
Tamantha K Littlejohn, Osamu Takikawa, Daniel Skylas, Joanne F Jamie, Mark J Walker, Roger JW Truscott, None, Expression and Purification of Recombinant Human Indoleamine 2,3-Dioxygenase Protein Expression and Purification. ,vol. 19, pp. 22- 29 ,(2000) , 10.1006/PREP.2000.1214
Catherine Uyttenhove, Luc Pilotte, Ivan Théate, Vincent Stroobant, Didier Colau, Nicolas Parmentier, Thierry Boon, Benoît J Van den Eynde, None, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nature Medicine. ,vol. 9, pp. 1269- 1274 ,(2003) , 10.1038/NM934
Mark Salter, Robert Hazelwood, Christopher I. Pogson, Ramachandran Iyer, David J. Madge, The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat. Biochemical Pharmacology. ,vol. 49, pp. 1435- 1442 ,(1995) , 10.1016/0006-2952(95)00006-L
Prapairat Seephonkai, Aphidech Sangdee, Pasakorn Bunchalee, Stephen G. Pyne, Cytotoxic and antiplasmodial compounds from the roots of Strophioblachia fimbricalyx. Journal of Natural Products. ,vol. 72, pp. 1892- 1894 ,(2009) , 10.1021/NP900352N
Eduardo Vottero, Aruna Balgi, Kate Woods, Stuart Tugendreich, Teri Melese, Raymond J. Andersen, A. Grant Mauk, Michel Roberge, Inhibitors of human indoleamine 2,3‐dioxygenase identified with a target‐based screen in yeast Biotechnology Journal. ,vol. 1, pp. 282- 288 ,(2006) , 10.1002/BIOT.200600001
Ute F. Röhrig, Somi Reddy Majjigapu, Aurélien Grosdidier, Sylvian Bron, Vincent Stroobant, Luc Pilotte, Didier Colau, Pierre Vogel, Benoît J. Van den Eynde, Vincent Zoete, Olivier Michielin, Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition Journal of Medicinal Chemistry. ,vol. 55, pp. 5270- 5290 ,(2012) , 10.1021/JM300260V
Paul Gaspari, Tinku Banerjee, William P. Malachowski, Alexander J. Muller, George C. Prendergast, James DuHadaway, Shauna Bennett, Ashley M. Donovan, Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. Journal of Medicinal Chemistry. ,vol. 49, pp. 684- 692 ,(2006) , 10.1021/JM0508888